These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8782905)

  • 41. Parenterally administered 3-nitropropionic acid and amphetamine can combine to produce damage to terminals and cell bodies in the striatum.
    Bowyer JF; Clausing P; Schmued L; Davies DL; Binienda Z; Newport GD; Scallet AC; Slikker W
    Brain Res; 1996 Mar; 712(2):221-9. PubMed ID: 8814896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age- and region-dependent alterations in the GABAergic innervation in the brain of rats treated with amphetamine.
    Yin HS; Chen CT; Lin TY
    Int J Neuropsychopharmacol; 2004 Mar; 7(1):35-48. PubMed ID: 14725721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of increases in impulse flow.
    Tepper JM; Young SJ; Groves PM
    Brain Res; 1984 Sep; 309(2):309-16. PubMed ID: 6089959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The effect of the activation and blockade of the neostriatal dopaminergic system on the hyperkinesis evoked in rats by the intrastriatal administration of picrotoxin].
    Iakimovskiĭ AF
    Biull Eksp Biol Med; 1993 Jul; 116(7):9-10. PubMed ID: 8400197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The food-acquisition behavior of rats under conditions of the chronic activation and blockade of the neostriatal dopaminergic system].
    Iakimovskiĭ AF; Filatova EV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1994; 44(4-5):731-7. PubMed ID: 7810215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioral electrophysiology of psychostimulants.
    Rebec GV
    Neuropsychopharmacology; 2006 Nov; 31(11):2341-8. PubMed ID: 16855534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of long-term amphetamine administration on the activity of dopaminergic neurons of the substantia nigra.
    Staunton DA; Young SJ; Groves PM
    Brain Res; 1980 Apr; 188(1):107-17. PubMed ID: 6989446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopaminergic and neostriatal neurons: dose-dependent changes in sensitivity to amphetamine following long-term treatment.
    Kamata K; Rebec GV
    Neuropharmacology; 1983 Dec; 22(12A):1377-82. PubMed ID: 6664466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electronmicroscopic investigation of rat substantia nigra after chronic amphetamine treatment. I. Changes in the neurones.
    Petrov I; Lolova I
    Acta Physiol Pharmacol Bulg; 1977; 3(3):24-32. PubMed ID: 612126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential regulation of calmodulin content and calmodulin messenger RNA levels by acute and repeated, intermittent amphetamine in dopaminergic terminal and midbrain areas.
    Michelhaugh SK; Gnegy ME
    Neuroscience; 2000; 98(2):275-85. PubMed ID: 10854758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differing properties of putative fast-spiking interneurons in the striatum of two rat strains.
    Perk CG; Wickens JR; Hyland BI
    Neuroscience; 2015 May; 294():215-26. PubMed ID: 25758937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testosterone attenuates and the selective estrogen receptor modulator, raloxifene, potentiates amphetamine-induced locomotion in male rats.
    Purves-Tyson TD; Boerrigter D; Allen K; Zavitsanou K; Karl T; Djunaidi V; Double KL; Desai R; Handelsman DJ; Weickert CS
    Horm Behav; 2015 Apr; 70():73-84. PubMed ID: 25747465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-dose amphetamine elevates movement-related firing of rat striatal neurons.
    West MO; Peoples LL; Michael AJ; Chapin JK; Woodward DJ
    Brain Res; 1997 Jan; 745(1-2):331-5. PubMed ID: 9037428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amphetamine treatment during the preweanling period produces enduring changes in striatal protein kinase A activity.
    Crawford CA; Zavala AR; Karper PE; Collins RL; Loring-Meier T; Watson JB; McDougall SA
    Pharmacol Biochem Behav; 2000 Aug; 66(4):835-40. PubMed ID: 10973523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amphetamine inhibits behavior-related neuronal responses in substantia nigra pars reticulata of rats working for sucrose reinforcement.
    Gulley JM; Kosobud AE; Rebec GV
    Neurosci Lett; 2002 Apr; 322(3):165-8. PubMed ID: 11897164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasticity of striatopallidal terminals following unilateral lesion of the dopaminergic nigrostriatal pathway: a morphological study.
    Ingham CA; Hood SH; Mijnster MJ; Baldock RA; Arbuthnott GW
    Exp Brain Res; 1997 Aug; 116(1):39-49. PubMed ID: 9305813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electronmicroscopic investigation of rat substantia nigra after chronic amphetamine treatment. II. Changes in the glial cells and blood vessels.
    Petrov I
    Acta Physiol Pharmacol Bulg; 1977; 3(3):33-41. PubMed ID: 612128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The expression of amphetamine sensitization is dissociable from anxiety and aversive memory: Effect of an acute injection of amphetamine.
    Gatica RI; Pérez-Valenzuela E; Sierra-Mercado D; Fuentealba JA
    Neurosci Lett; 2017 Jan; 638():21-26. PubMed ID: 27939979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mesocortical dopaminergic neurons. 2. Electrophysiological consequences of terminal autoreceptor activation.
    Gariano RF; Sawyer SF; Tepper JM; Young SJ; Groves PM
    Brain Res Bull; 1989 Mar; 22(3):517-23. PubMed ID: 2713724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuronal and behavioral correlates of intrastriatal infusions of amphetamine in freely moving rats.
    Wang Z; Rebec GV
    Brain Res; 1993 Nov; 627(1):79-88. PubMed ID: 8293307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.